市場調查報告書
商品編碼
1541705
2024-2032 年醫療美容市場報告(按產品(設備、美容植入物)、應用(手術、非手術)、最終用戶(醫院和診所、醫療水療中心和美容中心)和地區)Medical Aesthetics Market Report by Product (Devices, Aesthetic Implants), Application (Surgical, Non Surgical), End User (Hospitals and Clinics, Medical Spas and Beauty Centers), and Region 2024-2032 |
IMARC Group年全球醫學美容市場規模達168億美元。該市場的主要促進因素是人們對年輕外表和自信的日益重視、消費者對非侵入性整容手術的需求不斷成長、技術的不斷進步以及醫學美容的廣泛普及和可及性。
主要市場促進因素:肉毒桿菌、真皮填充劑和雷射治療等非侵入性或微創手術的日益普及,是推動醫療美容市場前景的關鍵因素之一。此外,越來越多的社群媒體平台和不斷成長的名人文化也在催化全球市場。此外,醫療領域的不斷進步,包括雷射技術、超音波治療和先進的注射劑,以開發更有效、更安全的方法,正在對市場成長產生積極影響。
主要市場趨勢:消費者對根據個人需求和偏好量身定做的個人化治療計劃的需求不斷成長,這是一個重要的成長誘導因素。除此之外,注射劑、雷射治療、射頻治療和護膚程序等聯合療法的新興趨勢也刺激了醫療美容市場的統計數據。
競爭格局:醫療美容行業的一些主要市場參與者包括 ARC Laser Gmbh、AbbVie Inc.、Alma Lasers Ltd.、Bausch Health Companies Inc.、Cutera Inc.、Cynosure、El.En。 SpA、Fotona doo、強生、Lutronic、Merz Pharma GmbH & Co. KGaA、Venus Concept 等。
地理趨勢:由於化妝品行業的不斷擴大、醫療基礎設施的先進以及個人對自我完善和個人外表的日益關注,北美佔據了最大的市場佔有率。除此之外,消費者對手術和非手術美容治療偏好的轉變也促進了該地區醫療美容市場的成長。
挑戰與機會:政府機構實施嚴格的法規可能會為市場准入、產品核准和安全標準合規帶來眾多挑戰。然而,人工智慧(AI)、機器人和3D列印等先進技術的日益普及,為醫學美容行業的成長提供了巨大的成長機會。
對非侵入性手術的需求不斷成長
對非侵入性手術的需求不斷成長主要推動了市場的成長。除此之外,消費者對美容增強的偏好的轉變也促進了醫學美容市場的前景。此外,各種美容療程的日益普及,如真皮填充劑、肉毒桿菌注射和雷射療法,進一步促進了市場的成長。例如,2021 年 7 月,艾爾建 (Allergan) 獲得美國 FDA 批准 BOTOX 標籤擴展,包括八種新肌肉,用於治療成人上肢痙攣。用於治療的新肌肉包括手肘和前臂的額外肌肉(肱肌、肱橈肌、旋前圓肌和旋前方肌)。美國整形外科醫生協會的研究發現,肉毒桿菌注射是 2020 年最受歡迎的非侵入性整容手術,全年進行了 440 萬例手術。因此,肉毒桿菌毒素在美容醫學中的使用顯著增加。肉毒桿菌注射用於治療皺眉紋、魚尾紋和額頭橫紋,這些都是美國 FDA 批准的美容適應症。
持續的技術進步
雷射技術、注射和能量設備的持續創新正在對市場成長產生積極影響。此外,由於先進技術的有效性和多功能性,針對特定皮膚問題(包括色素沉著、皺紋和紋身去除)的需求不斷提高,也促進了醫學美容行業的成長。例如,達文西手術系統等手術機器人的廣泛使用為外科醫生在微創手術過程中提供了更高的精確度、靈巧性和控制力,從而徹底改變了手術領域。此外,更持久、更自然的注射劑的日益流行也刺激了醫療美容市場的需求,這些注射劑使美容增強更容易獲得併吸引個人。例如,乳房美容領域的歷史悠久的品牌 GC Aesthetics 和醫療保健解決方案的先驅 Bimini Health Tech(“Bimini”)宣佈建立合資夥伴關係,旨在徹底改變全球乳房重建。這項策略合作將 GC Aesthetics 在矽膠乳房植入物設計、製造和分銷方面 40 年的經驗與 Bimini 在乳房重建創新方面的專業知識相結合。結果是:前所未有地致力於為全球(包括美國、拉丁美洲、歐洲、中東和非洲和亞太地區)女性提供一流的乳房重建解決方案。
人們越來越重視自信和年輕的外表
根據醫療美容市場概況,優先考慮自信和年輕的文化轉變是支撐醫療美容市場的主要因素之一。此外,各個監管機構對產品的批准也促進了市場的成長。例如,2022 年 1 月,Lumenis 在英國推出了 Splendor X 設備,該設備獲得了 CE 許可,用於除毛、血管治療、色素性病變和皺紋。此外,肉毒桿菌毒素治療的日益普及、愛美人群的不斷增加以及產品的推出也推動了該細分市場的成長。肉毒桿菌毒素是由肉毒桿菌產生的神經毒性蛋白質。肉毒桿菌注射往往會阻斷注射肌肉的神經訊號。另據報導,31-45 歲的患者最常尋求 A 型肉毒桿菌美容手術。除此之外,ISAPS於2021年12月發布的一項調查顯示,2020年全球進行的所有非手術整容手術中,43.2%是肉毒桿菌手術。
IMARC Group提供了對每個細分市場的主要趨勢的分析,以及 2024-2032 年全球、區域、國家層面的預測。我們的報告根據產品、應用和最終用戶對市場進行了分類。
裝置
美容植入物
該報告根據產品提供了詳細的市場細分和分析。這包括設備和美容植入物。根據該報告,美容植入物代表了最大的部分。美容植入物越來越受歡迎,例如隆乳和臉部增強手術,正在推動市場成長。例如,2022年5月,GC Aesthetics, Inc.推出了FixNip NRI,即乳頭乳暈複合體重建植入物,以滿足女性的臨床需求。此外,消費者對個人化、自然效果的需求不斷成長也促進了市場的成長。
外科
非手術
該報告根據應用程式提供了詳細的市場細分和分析。這包括手術和非手術。報告稱,手術佔據了最大的市場佔有率。由於能夠提供全面且持久的效果,醫療美容外科手術的日益普及,主要推動了市場的成長。例如,GC Aesthetics 在歐洲推出了下一代乳房植入物 PERLE,這是一個採用表面技術 (BioQ) 的高度創新的光滑乳房植入物系列。此次發布幫助該公司提供了最廣泛的產品組合,包括完整的表面、填充物、尺寸和投影選擇,以滿足每位患者和外科醫生對重建和美容手術的需求。
醫院和診所
醫療水療美容中心
該報告提供了基於最終用戶的詳細市場細分和分析。這包括醫院和診所以及醫療水療中心和美容中心。報告稱,醫院和診所是最大的部分。這些老牌醫療機構憑藉其經驗豐富的醫護人員和全面的資源,提供各種醫美服務。此外,醫院和診所是尋求手術治療的患者的首選,因為它們為複雜的治療提供了安全且受監管的環境。
北美洲
美國
加拿大
亞太
中國
日本
印度
韓國
澳洲
印尼
其他
歐洲
德國
法國
英國
義大利
西班牙
俄羅斯
其他
拉丁美洲
巴西
墨西哥
其他
中東和非洲
該報告還對所有主要區域市場進行了全面分析,其中包括北美(美國和加拿大);歐洲(德國、法國、英國、義大利、西班牙、俄羅斯等);亞太地區(中國、日本、印度、韓國、澳洲、印尼等);拉丁美洲(巴西、墨西哥等);以及中東和非洲。報告稱,由於醫療保健基礎設施的不斷發展以及手術和非手術整容手術的需求不斷增加,北美佔據了最大的市場佔有率。除此之外,不斷增加的產品推出和領先企業的高度集中也推動了市場的成長。例如,Alma Lasers 推出了 Alma PrimeX,這是用於身體輪廓和皮膚緊緻的終極非侵入性平台。此外,醫療機構數量的增加和先進技術的利用也刺激了該地區市場的成長。例如,NanoPass Technologies 和 Aesthetic Management Partners (AMP) 簽署了一項協議,將 NanoPass 的 MicronJet 600 皮內輸送設備在美國商業化。
市場研究報告也對市場競爭格局進行了全面分析。報告涵蓋了市場結構、關鍵參與者定位、最佳制勝策略、競爭儀表板和公司評估象限等競爭分析。此外,也提供了所有主要公司的詳細資料。醫學美容行業的一些主要市場參與者包括 ARC Laser Gmbh、AbbVie Inc.、Alma Lasers Ltd.、Bausch Health Companies Inc.、Cutera Inc.、Cynosure、El.En。 SpA、Fotona doo、強生、Lutronic、Merz Pharma GmbH & Co. KGaA、Venus Concept 等。
(請注意,這只是關鍵參與者的部分列表,報告中提供了完整列表。)
2023 年 10 月:乳房美容領域歷史悠久的品牌 GC Aesthetics 與醫療保健解決方案先驅 Bimini Health Tech(「Bimini」)宣佈建立突破性的合資夥伴關係,旨在徹底改變全球乳房重建。這項策略合作將 GC Aesthetics 在矽膠乳房植入物設計、製造和分銷方面 40 年的經驗與 Bimini 在乳房重建創新方面的專業知識相結合。
2024 年 1 月:United Aesthetics Alliance(「UAA」或「公司」)是一家控股公司,旨在鞏固市場領先的臨床差異化整形外科實踐和附屬醫療水療服務提供商,今天宣布它最近與 The本特森美容與整形外科中心(“BCAPS”或“診所”)。
2024 年 2 月:新興的純皮膚科領域領導者 Galderma 推出了「NEXT by Galderma」。 NEXT 是一份開創性的報告,深入探討了 2024 年及以後的全球美學趨勢。該計畫是與知名專家網路合作進行的一年全面趨勢預測研究的結晶。
2024 年 3 月:全球最大的專業醫療美容企業之一 Merz Aesthetics 宣布對其首個多年期活動“Beauty on Your terms”進行最新擴展,並邀請了獲獎演員和音樂家Demi Lovato 成為最新的XEOMIN (incobotulinumtoxinA ) 品牌合作夥伴。
The global medical aesthetics market size reached US$ 16.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 35.7 Billion by 2032, exhibiting a growth rate (CAGR) of 8.6% during 2024-2032. The market is primarily driven by the rising emphasis on youthful appearance and self-confidence, the escalating consumer demand for non-invasive cosmetic procedures, the continuous technological advancements, and the widespread availability and accessibility of medical aesthetics.
Major Market Drivers: The growing popularity of non-invasive or minimally invasive procedures, such as Botox, dermal fillers, and laser treatments, is among the key factors propelling the medical aesthetics market outlook. Moreover, the increasing number of social media platforms and the growing celebrity culture are also catalyzing the global market. Additionally, the continuous advances in the medical field, including laser technology, ultrasound treatments, and advanced injectables for the development of more effective and safer methods, are positively influencing the market growth.
Key Market Trends: The escalating consumer demand for personalized treatment plans tailored to their individual needs and preferences is acting as a significant growth-inducing factor. Besides this, the emerging trend of combination therapies, such as injectables, laser cures, radiofrequency treatments, and skincare routines to achieve optimal outcomes is also stimulating the medical aesthetics market statistics.
Competitive Landscape: Some of the major market players in the medical aesthetics industry include A.R.C. Laser Gmbh, AbbVie Inc., Alma Lasers Ltd., Bausch Health Companies Inc., Cutera Inc., Cynosure, El.En. S.p.A., Fotona d.o.o., Johnson & Johnson, Lutronic, Merz Pharma GmbH & Co. KGaA, Venus Concept, among many others.
Geographical Trends: North America accounted for the largest market share, on account of the expanding cosmetic industry, the advanced medical infrastructure, and the increasing focus on self-improvement and individual appearance among individuals. Apart from this, the shifting consumer preferences towards surgical and non-surgical beauty treatments are also catalyzing the market growth of medical aesthetics in the region.
Challenges and Opportunities: The implementation of stringent regulations by government bodies can pose numerous challenges for market entry, product approval, and compliance with safety standards. However, the growing popularity of advanced technologies, including artificial intelligence (AI), robotics, and 3D printing, presents significant growth opportunities for the medical aesthetics industry growth.
Growing Demand for Non-Invasive Procedures
The escalating demand for non-invasive procedures is primarily driving the market growth. Besides this, the shifting consumer preferences towards cosmetic enhancements are also catalyzing the medical aesthetics market outlook. Moreover, the growing popularity of various beauty treatments, such as dermal fillers, Botox injections, and laser therapy is further augmenting the market growth. For instance, in July 2021, Allergan received the US FDA approval of a label expansion of BOTOX to include eight new muscles for the treatment of upper limb spasticity in adults. The new muscles for treatment include additional muscles of the elbow and forearm (brachialis, brachioradialis, pronator teres, and pronator quadratus). The American Society of Plastic Surgeons study found that Botox injections were the most popular non-invasive cosmetic procedure in 2020, with 4.4 million procedures performed in the year. Hence, the use of botulinum toxins in aesthetic medicine has increased remarkably. Botox injections are used to treat frown lines, crow's feet, and horizontal forehead lines, which are cosmetic indications approved by the US FDA.
Ongoing Technological Advancements
The ongoing innovations in laser technology, injectables, and energy-based devices are positively influencing the market growth. Moreover, the elevating requirement for advanced technologies to target specific skin issues, including pigmentation, wrinkles, and tattoo removal, owing to their effectiveness and versatility, is also catalyzing the medical aesthetics industry growth. For example, the extensive utilization of surgical robots, such as the da Vinci Surgical System, has revolutionized the field of surgery by providing enhanced precision, dexterity, and control to surgeons during minimally invasive procedures. Additionally, the growing popularity of longer-lasting and more natural-looking injectables to make cosmetic enhancements more accessible and appealing to individuals is also stimulating the medical aesthetics market demand. For instance, GC Aesthetics, a long-established brand in breast aesthetics, and Bimini Health Tech ("Bimini"), a pioneer in healthcare solutions, announced their joint venture partnership aimed at revolutionizing breast reconstruction worldwide. This strategic collaboration combines GC Aesthetics' 40 years' experience in design, manufacturing, and distribution of Silicone Breast Implants with Bimini's expertise in Breast Reconstruction innovation. The result: an unprecedented commitment to providing women with best-in-class solutions for breast reconstruction across the globe, including the USA, LATAM, EMEA, and APAC.
Rising Emphasis on Self-Confidence and Youthful Appearance
As per the medical aesthetics market overview, the rising cultural shift towards prioritizing self-assurance and youthfulness is among the primary factors bolstering the medical aesthetics market. Additionally, the approval of products by various regulatory authorities is also boosting the market's growth. For instance, in January 2022, Lumenis launched the Splendor X device, CE cleared for hair removal, vascular treatments, pigmented lesions, and wrinkles in the United Kingdom. Moreover, the growing popularity of botulinum toxin procedures, the increasing beauty-conscious populations, and the launch of products are also propelling the growth of the market segment. Botulinum toxin is a neurotoxic protein produced by the bacterium clostridium botulinum. The botulinum toxin injections tend to block the nerve signals to the muscle in which it is injected. It is also reported that patients aged 31- 45 year most commonly seek botulinum toxin type A cosmetic procedures. Apart from this, an ISAPS survey released in December 2021 revealed that among all the non-surgical cosmetic procedures performed globally in 2020, 43.2% were Botulinum Toxin procedures.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, country levels for 2024-2032. Our report has categorized the market based on product, application, and end user.
Devices
Aesthetic Implants
The report has provided a detailed breakup and analysis of the market based on the product. This includes devices and aesthetic implants. According to the report, aesthetic implants represented the largest segment. The growing popularity of aesthetic implants for procedures, such as breast augmentation and facial enhancements is propelling the market growth. For example, in May 2022, GC Aesthetics, Inc. launched FixNip NRI, its Nipple Areola Complex Reconstruction Implants, to cater to women's clinical needs. Moreover, the escalating consumer demand for personalized, natural-looking results is also catalyzing the market growth.
Surgical
Non Surgical
The report has provided a detailed breakup and analysis of the market based on the application. This includes surgical and non-surgical. According to the report, surgical accounted for the largest market share. The growing popularity of surgical procedures in medical aesthetics, on account of their ability to provide comprehensive and long-lasting results, is primarily driving the market growth. For instance, GC Aesthetics launched PERLE, the next generation of breast implants, a highly innovative line of smooth breast implants with surface technology (BioQ), in Europe. This launch helped the company to offer the broadest product portfolio with a full selection of surfaces, fillings, sizes, and projections to meet every patient's and surgeon's demands for both reconstructive and aesthetic procedures.
Hospitals and Clinics
Medical Spas and Beauty Centers
The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals and clinics and medical spas and beauty centers. According to the report, hospitals and clinics represented the largest segment. These established healthcare facilities provide various medical aesthetic services, on account of their experienced medical staff and comprehensive resources. Moreover, hospitals and clinics are a preferred choice for patients seeking surgical procedures, as they offer a secure and regulated environment for complex treatments.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share, owing to the increasing healthcare infrastructure development and the escalating demand for surgical and non-surgical cosmetic procedures. Apart from this, the rising product launches and the high concentration of leading players are also propelling the market growth. For example, Alma Lasers launched Alma PrimeX, the ultimate non-invasive platform for body contouring and skin tightening. Moreover, the elevating number of medical institutions and the utilization of advanced technologies are also stimulating the growth of the market in the region. For instance, NanoPass Technologies and Aesthetic Management Partners (AMP) signed an agreement to commercialize NanoPass's MicronJet 600 intradermal delivery device in the United States.
The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the major market players in the Medical Aesthetics industry include A.R.C. Laser Gmbh, AbbVie Inc., Alma Lasers Ltd., Bausch Health Companies Inc., Cutera Inc., Cynosure, El.En. S.p.A., Fotona d.o.o., Johnson & Johnson, Lutronic, Merz Pharma GmbH & Co. KGaA, Venus Concept, among many others.
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
October 2023: GC Aesthetics, a long-established brand in breast aesthetics, and Bimini Health Tech ("Bimini"), a pioneer in healthcare solutions, announced their groundbreaking Joint Venture partnership aimed at revolutionizing breast reconstruction worldwide. This strategic collaboration combines GC Aesthetics' 40 years' experience in design, manufacturing, and distribution of Silicone Breast Implants with Bimini's expertise in Breast Reconstruction innovation.
January 2024: United Aesthetics Alliance ("UAA" or "the Company"), a holding company created to consolidate market-leading, clinically differentiated plastic surgery practices and affiliated medical spa service providers, today announced it has recently established a new partnership with The Bengtson Center for Aesthetics & Plastic Surgery ("BCAPS" or "the Practice").
February 2024: Galderma, the emerging pure-play dermatology category leader, presented "NEXT by Galderma." A ground-breaking report, NEXT takes a deep-dive into the global aesthetics trends set to shape 2024 and beyond. This project is the culmination of a year of comprehensive trend-forecasting research, conducted in collaboration with a network of renowned experts.
March 2024: Merz Aesthetics, the one of the world's largest dedicated medical aesthetics businesses, announced the latest extension of their first-of-its kind, multi-year campaign, 'Beauty on Your Terms' with the addition of award-winning actor and musician Demi Lovato as the newest XEOMIN (incobotulinumtoxinA) brand partner.